Dumont N - Search Results

1

Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells.

Criswell TL, Dumont N, Barnett JV, Arteaga CL. Criswell TL, et al. Among authors: dumont n. Cancer Res. 2008 Sep 15;68(18):7304-12. doi: 10.1158/0008-5472.CAN-07-6777. Cancer Res. 2008. PMID: 18794117

2

Invasion and metastasis of a mammary tumor involves TGF-beta signaling.

McEarchern JA, Kobie JJ, Mack V, Wu RS, Meade-Tollin L, Arteaga CL, Dumont N, Besselsen D, Seftor E, Hendrix MJ, Katsanis E, Akporiaye ET. McEarchern JA, et al. Among authors: dumont n. Int J Cancer. 2001 Jan 1;91(1):76-82. doi: 10.1002/1097-0215(20010101)91:1<76::aid-ijc1012>3.0.co;2-8. Int J Cancer. 2001. PMID: 11149423

3

Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-beta.

Dumont N, Arteaga CL. Dumont N, et al. Breast Cancer Res. 2000;2(2):125-32. doi: 10.1186/bcr44. Epub 2000 Feb 21. Breast Cancer Res. 2000. PMID: 11250702 Free PMC article. Review.

4

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

Muraoka RS, Dumont N, Ritter CA, Dugger TC, Brantley DM, Chen J, Easterly E, Roebuck LR, Ryan S, Gotwals PJ, Koteliansky V, Arteaga CL. Muraoka RS, et al. Among authors: dumont n. J Clin Invest. 2002 Jun;109(12):1551-9. doi: 10.1172/JCI15234. J Clin Invest. 2002. PMID: 12070302 Free PMC article.

5

Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.

Law BK, Chytil A, Dumont N, Hamilton EG, Waltner-Law ME, Aakre ME, Covington C, Moses HL. Law BK, et al. Among authors: dumont n. Mol Cell Biol. 2002 Dec;22(23):8184-98. doi: 10.1128/MCB.22.23.8184-8198.2002. Mol Cell Biol. 2002. PMID: 12417722 Free PMC article.

6

Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.

Dumont N, Bakin AV, Arteaga CL. Dumont N, et al. J Biol Chem. 2003 Jan 31;278(5):3275-85. doi: 10.1074/jbc.M204623200. Epub 2002 Nov 5. J Biol Chem. 2003. PMID: 12421823 Free article.

7

The tumor microenvironment: a potential arbitrator of the tumor suppressive and promoting actions of TGFbeta.

Dumont N, Arteaga CL. Dumont N, et al. Differentiation. 2002 Dec;70(9-10):574-82. doi: 10.1046/j.1432-0436.2002.700910.x. Differentiation. 2002. PMID: 12492498 Review.

8

A kinase-inactive type II TGFbeta receptor impairs BMP signaling in human breast cancer cells.

Dumont N, Arteaga CL. Dumont N, et al. Biochem Biophys Res Commun. 2003 Jan 31;301(1):108-12. doi: 10.1016/s0006-291x(02)02977-7. Biochem Biophys Res Commun. 2003. PMID: 12535648

9

Targeting the TGF beta signaling network in human neoplasia.

Dumont N, Arteaga CL. Dumont N, et al. Cancer Cell. 2003 Jun;3(6):531-6. doi: 10.1016/s1535-6108(03)00135-1. Cancer Cell. 2003. PMID: 12842082 Free article. Review. No abstract available.

10

Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.

Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL. Ueda Y, et al. Among authors: dumont n. J Biol Chem. 2004 Jun 4;279(23):24505-13. doi: 10.1074/jbc.M400081200. Epub 2004 Mar 24. J Biol Chem. 2004. PMID: 15044465 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters